Search results
NIH Phase Ib/II DLBCL drug combo trial reports 34% complete response
Clinical Trials Arena via Yahoo Finance· 3 days agoA five drug combination drug therapy trial has shown substantial tumour shrinking in more than half...
Promising outcomes with liso-cel in patients with R/R follicularlymphoma - Nature Reviews Clinical...
Nature· 3 days agoPatients with follicular lymphoma (FL) generally have favourable outcomes after receiving first-line immunochemotherapy; however, treatment options are limited for those with ...
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
MedPage Today· 5 days agoHigh-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line
Researchers uncover mechanism that fuels growth of aggressive B-cell lymphoma
Science Daily· 6 days agoThe KLHL6 protein is part of a cellular system tasked with disposing of excess and unnecessary proteins. In many cancers, this system is disrupted, which advances malignant growth. The researchers ...
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
Zacks via Yahoo Finance· 6 days agoRoche's (RHHBY) Columvi significantly extends survival in patients with relapsed or refractory...
Kymera shares hold Buy rating on PoC data By Investing.com
Investing.com· 6 days agoKT-333's mechanism of action was further supported by biomarker data regarding STAT3, phosphorylated...
Marijuana and guns: Should pot use limit the ability to get a gun license?
Newsday· 14 hours agoFor the past two-plus years, Mark Humphreys has been both a licensed pistol owner and a medical...
Local car dealership teams up with cancer org to support Sparrow cancer patients
WILX 10 Lansing· 2 days agoFriday, Williams Subaru of Lansing teamed up with the Leukemia and Lymphoma Society to support...
Music therapy helps two-time cancer survivor throu | Newswise
Newswise· 3 days agoLEXINGTON, Ky. (June 21, 2024) – In 2018, Bobbi Jo Allen was exercising when she found a lump in her...
Buckingham Capital Management Inc. Sells 94 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 10 hours agoBuckingham Capital Management Inc. cut its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 7.1% during the 1st quarter, Holdings Channel.com reports. The institutional investor ...